Psychiatry and Neurology, Neurology · Tulsa, OK
NPI
1275560708
Since 2006
Specialty
Psychiatry and Neurology, Neurology
Code 2084N0400X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
9001 S 101st East Ave Ste 190
Tulsa, OK, 74133
Phone (918) 579-3870
Groups this clinician bills Medicare through
Medicare paid, 2024
$144K
8,547 services
Medicare patients, 2024
558
Average age 71
Drug cost, 2024
$6.1M
4,461 prescriptions
Company payments, 2025
$7,134
From 38 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Randall Webb was code J0585 (injection, onabotulinumtoxina, 1 unit), 7,345 times for 12 patients. In total Randall Webb billed 8,547 services in 32 codes, and Medicare paid $144K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2022-01-12.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J0585 Injection, onabotulinumtoxina, 1 unit | Office | 7,345 | 12 | $4.97 | $36K |
| 95720 Neurologic | Facility | 244 | 85 | $148.00 | $36K |
| 95886 Electrical Nerve Conductivity | Office | 244 | 129 | $68.02 | $17K |
| 99214 Office E&M - Established | Office | 205 | 136 | $78.43 | $16K |
| 95819 Neurologic | Facility | 141 | 132 | $40.16 | $5,663 |
| 95910 Electrical Nerve Conductivity | Office | 49 | 48 | $113.86 | $5,579 |
| 95909 Electrical Nerve Conductivity | Office | 43 | 43 | $94.01 | $4,043 |
| 95822 Neurologic | Facility | 37 | 36 | $41.72 | $1,544 |
| 99215 Office E&M - Established | Office | 36 | 29 | $119.56 | $4,304 |
| 95908 Electrical Nerve Conductivity | Office | 28 | 28 | $72.61 | $2,033 |
| 99213 Office E&M - Established | Office | 25 | 24 | $58.35 | $1,459 |
| 95718 Neurologic | Facility | 17 | 15 | $98.91 | $1,681 |
| 99443 Telephone Services | Office | 14 | 13 | $70.98 | $994 |
By year: 2022 $113K for 7,602 services; 2023 $146K for 8,780 services; 2024 $144K for 8,547 services.
Medicare prescription drug claims, 2024
In 2024, the drug Randall Webb prescribed most often to Medicare patients was Gabapentin, with 264 prescriptions and refills. In total Randall Webb wrote 4,461 Medicare prescriptions that cost $6.1M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Gabapentin Generic | 264 | 383 | 46 | $3,607 |
| Primidone Generic | 183 | 241 | 28 | $2,118 |
| Lamotrigine Generic | 164 | 217 | 24 | $2,657 |
| Baclofen Generic | 152 | 221 | 38 | $3,049 |
| Tizanidine Hcl Generic | 134 | 146 | 24 | $1,462 |
| Kesimpta Pen Ofatumumab | 114 | 114 | 16 | $1.2M |
| Pramipexole Dihydrochloride Pramipexole Di-Hcl | 110 | 149 | 18 | $1,800 |
| Carbidopa-Levodopa Carbidopa/Levodopa | 109 | 168 | 19 | $1,400 |
| Alprazolam Generic | 107 | 111 | 13 | $527 |
| Modafinil Generic | 106 | 120 | 18 | $5,301 |
| Carbidopa-Levodopa Er Carbidopa/Levodopa | 102 | 138 | 18 | $2,193 |
| Dextroamphetamine-Amphetamine Dextroamphetamine/Amphetamine | 96 | 96 | 12 | $2,642 |
| Levetiracetam Generic | 92 | 165 | 19 | $1,663 |
| Duloxetine Hcl Generic | 89 | 148 | 18 | $2,010 |
| Amantadine Amantadine Hcl | 88 | 121 | 17 | $3,959 |
Brand drugs: 786 claims; generic drugs: 3,648 claims; opioid claims: 103.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Randall Webb $7,134 ($7,134 in general payments such as food, travel and fees) from 38 companies. The largest payer was LivaNova USA, Inc. with $2,012.
| Company | Payments | Amount |
|---|---|---|
| LivaNova USA, Inc. LIVN | 10 | $2,012 |
| EMD Serono, Inc. MRK.DE | 27 | $1,302 |
| Novartis Pharmaceuticals Corporation NVS | 23 | $354 |
| Abbvie Inc. ABBV | 17 | $290 |
| Neurocrine BioSciences, Inc. NBIX | 15 | $238 |
| Pfizer Inc. PFE | 18 | $225 |
| TG Therapeutics, Inc. TGTX | 10 | $205 |
| Teva Pharmaceuticals USA, Inc. TEVA | 9 | $199 |
| Celgene Corporation BMY | 11 | $196 |
| Genentech USA, Inc. ROG.SW | 9 | $193 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.